BACKGROUND: The purpose of this study was to review our experiences treating @entity3657 ( @entity3657 ) by common femoral artery endarterectomy (CFE) with and without endovascular therapy (EVT), and to describe the role of CFE in the endovascular @entity7971 . METHODS: We retrospectively reviewed a contemporary series of 38 limbs from January 2010 to September 2014. Clinical outcomes of primary patency, assisted primary patency, limb salvage, and survival were analyzed with the Kaplan-Meier method. Multivariable perioperative predictors of primary patency were identified using the stepwise Cox proportional hazards regression model. RESULTS: Hemodynamic success was achieved in 36 of the 38 limbs (95%). The mean ankle brachial pressure index improved significantly, rising from 0.56    0.04 preoperatively to 0.89    0.04 postoperatively (P = 0.0001). Overall primary and assisted primary patency rates, respectively, were 90% and 100% at 12 months and 85% and 94% at 24 months. There was no significant difference in primary patency rate between isolated CFE and hybrid CFE plus EVT. Both limb salvage and survival rates were 97% at 12 months and 97% at 24 months. Multivariate Cox regression analysis revealed that no clinical or perioperative risk factors were predictive of decreased primary patency. CONCLUSIONS: CFE is a safe, effective, and durable procedure for common femoral @entity455 , and hybrid CFE plus EVT can be a valid alternative to open surgical bypass for multilevel occlusive @entity455 . These observations stress that CFE plays a vital role in the management of @entity3657 even in the endovascular @entity7971 .

The Role of Common Femoral Artery Endarterectomy in the Endovascular XXXX .

@entity7971 :: ('26284', 'Gene') :: ['era'] @entity455 :: ('MESH:D014652', 'Disease') :: ['artery disease'] @entity3657 :: ('MESH:D058729', 'Disease') :: ['peripheral artery disease', 'PAD']
@entity7971 :: (26284,Gene) :: ['Era']
